Racial Differences in Prevalence and Clinical Characteristics of Asthma-Chronic Obstructive Pulmonary Disease Overlap
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jo, Yong Suk | - |
dc.contributor.author | Hwang, Yong Il | - |
dc.contributor.author | Yoo, Kwang Ha | - |
dc.contributor.author | Lee, Myung Goo | - |
dc.contributor.author | Jung, Ki Suck | - |
dc.contributor.author | Shin, Kyeong-Cheol | - |
dc.contributor.author | Yoon, Hyoung Kyu | - |
dc.contributor.author | Kim, Deog Kyeom | - |
dc.contributor.author | Lee, Sang Yeub | - |
dc.contributor.author | Rhee, Chin Kook | - |
dc.date.accessioned | 2022-11-04T05:42:16Z | - |
dc.date.available | 2022-11-04T05:42:16Z | - |
dc.date.created | 2022-11-04 | - |
dc.date.issued | 2021-11-22 | - |
dc.identifier.issn | 2296-858X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/144619 | - |
dc.description.abstract | Background: This study examined the differences in the prevalence and clinical features of asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) with identical diagnostic criteria by race and ethnicity in two nationwide cohorts of COPD.Methods: We used data from the Korean COPD Subgroup Study (KOCOSS) and phase I of the US Genetic Epidemiology of COPD (COPDGene) study. We defined ACO by satisfying bronchodilator response (BDR) >15% and 400 ml and/or blood eosinophil count >= 300/mu l.Results: The prevalences of ACO according to ethnicity were non-Hispanic white (NHW), 21.4%; African American (AA), 17.4%; and Asian, 23.8%. Asian patients with ACO were older, predominantly male, with fewer symptoms, more severe airflow limitation, and fewer comorbidities than NHW and AA patients. During 1-year follow-up, exacerbations occurred in 28.2, 22.0, and 48.4% of NHW, AA, and Asian patients with ACO, respectively. Compared to patients with non-ACO from the same racial group, the risk for exacerbation was significantly higher in NHW and Asian patients with ACO [adjusted incident rate ratio (aIRR), 1.17; 95% CI, 1.01-1.36, and aIRR, 1.37; 95% CI, 1.09-1.71 for NHW and Asian patients with ACO, respectively]. Inhaled corticosteroid (ICS) reduced the risk for future exacerbation in total patients with ACO but the effect was not significant in each racial group.Conclusions: The prevalence of ACO was similar in the two cohorts using the same diagnostic criteria. The risk for future exacerbation was significantly higher in ACO, and the use of ICS reduced the risk for exacerbation in total patients with ACO. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | FRONTIERS MEDIA SA | - |
dc.subject | INHALED CORTICOSTEROID TREATMENT | - |
dc.subject | COPD OVERLAP | - |
dc.subject | RESPONSIVENESS | - |
dc.subject | EXACERBATIONS | - |
dc.subject | EPIDEMIOLOGY | - |
dc.subject | FEATURES | - |
dc.subject | RISK | - |
dc.title | Racial Differences in Prevalence and Clinical Characteristics of Asthma-Chronic Obstructive Pulmonary Disease Overlap | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Sang Yeub | - |
dc.identifier.doi | 10.3389/fmed.2021.780438 | - |
dc.identifier.scopusid | 2-s2.0-85120693955 | - |
dc.identifier.wosid | 000726553200001 | - |
dc.identifier.bibliographicCitation | FRONTIERS IN MEDICINE, v.8 | - |
dc.relation.isPartOf | FRONTIERS IN MEDICINE | - |
dc.citation.title | FRONTIERS IN MEDICINE | - |
dc.citation.volume | 8 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | INHALED CORTICOSTEROID TREATMENT | - |
dc.subject.keywordPlus | COPD OVERLAP | - |
dc.subject.keywordPlus | RESPONSIVENESS | - |
dc.subject.keywordPlus | EXACERBATIONS | - |
dc.subject.keywordPlus | EPIDEMIOLOGY | - |
dc.subject.keywordPlus | FEATURES | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | ACO | - |
dc.subject.keywordAuthor | asthma-COPD overlap | - |
dc.subject.keywordAuthor | COPDGene (UA Genetic Epidemiology of COPD) | - |
dc.subject.keywordAuthor | KOCOSS (Korean COPD Subgroup Study) | - |
dc.subject.keywordAuthor | racial and ethnic differences | - |
dc.subject.keywordAuthor | inhaled corticosteroid (ICS) | - |
dc.subject.keywordAuthor | exacerbation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.